nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.17	0.401	CbGbCtD
Donepezil—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.156	0.366	CbGbCtD
Donepezil—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0991	0.233	CbGbCtD
Donepezil—Fibroadenosis of breast—Cyclosporine—focal segmental glomerulosclerosis	0.0333	0.0605	CcSEcCtD
Donepezil—Fibroadenoma of breast—Cyclosporine—focal segmental glomerulosclerosis	0.0311	0.0564	CcSEcCtD
Donepezil—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.0286	CcSEcCtD
Donepezil—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0229	CcSEcCtD
Donepezil—Moexipril—ACE—focal segmental glomerulosclerosis	0.0123	1	CrCbGaD
Donepezil—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0215	CcSEcCtD
Donepezil—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00934	0.0169	CcSEcCtD
Donepezil—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.0152	CcSEcCtD
Donepezil—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.0152	CcSEcCtD
Donepezil—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00795	0.0144	CcSEcCtD
Donepezil—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0141	CcSEcCtD
Donepezil—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0141	CcSEcCtD
Donepezil—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0141	CcSEcCtD
Donepezil—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0141	CcSEcCtD
Donepezil—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00742	0.0135	CcSEcCtD
Donepezil—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.013	CcSEcCtD
Donepezil—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.0122	CcSEcCtD
Donepezil—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.0114	CcSEcCtD
Donepezil—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00621	0.0113	CcSEcCtD
Donepezil—HTR2A—arteriole—focal segmental glomerulosclerosis	0.00603	0.566	CbGeAlD
Donepezil—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.0109	CcSEcCtD
Donepezil—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00584	0.0106	CcSEcCtD
Donepezil—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0105	CcSEcCtD
Donepezil—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.0104	CcSEcCtD
Donepezil—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.0103	CcSEcCtD
Donepezil—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.00906	CcSEcCtD
Donepezil—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.009	CcSEcCtD
Donepezil—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.009	CcSEcCtD
Donepezil—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.009	CcSEcCtD
Donepezil—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00882	CcSEcCtD
Donepezil—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00483	0.00876	CcSEcCtD
Donepezil—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0086	CcSEcCtD
Donepezil—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0086	CcSEcCtD
Donepezil—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0086	CcSEcCtD
Donepezil—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00443	0.00804	CcSEcCtD
Donepezil—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.0079	CcSEcCtD
Donepezil—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00773	CcSEcCtD
Donepezil—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00752	CcSEcCtD
Donepezil—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.00748	CcSEcCtD
Donepezil—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.00714	CcSEcCtD
Donepezil—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.0071	CcSEcCtD
Donepezil—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.00683	CcSEcCtD
Donepezil—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0067	CcSEcCtD
Donepezil—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00661	CcSEcCtD
Donepezil—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00646	CcSEcCtD
Donepezil—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00641	CcSEcCtD
Donepezil—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.00635	CcSEcCtD
Donepezil—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00632	CcSEcCtD
Donepezil—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.0063	CcSEcCtD
Donepezil—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00622	CcSEcCtD
Donepezil—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00611	CcSEcCtD
Donepezil—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00609	CcSEcCtD
Donepezil—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00609	CcSEcCtD
Donepezil—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00594	CcSEcCtD
Donepezil—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00589	CcSEcCtD
Donepezil—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00585	CcSEcCtD
Donepezil—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00563	CcSEcCtD
Donepezil—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00557	CcSEcCtD
Donepezil—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.00545	CcSEcCtD
Donepezil—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00543	CcSEcCtD
Donepezil—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00535	CcSEcCtD
Donepezil—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.00526	CcSEcCtD
Donepezil—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00524	CcSEcCtD
Donepezil—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00517	CcSEcCtD
Donepezil—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00513	CcSEcCtD
Donepezil—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00503	CcSEcCtD
Donepezil—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.005	CcSEcCtD
Donepezil—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00494	CcSEcCtD
Donepezil—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00492	CcSEcCtD
Donepezil—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.0048	CcSEcCtD
Donepezil—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00474	CcSEcCtD
Donepezil—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00467	CcSEcCtD
Donepezil—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00465	CcSEcCtD
Donepezil—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00463	CcSEcCtD
Donepezil—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0046	CcSEcCtD
Donepezil—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00458	CcSEcCtD
Donepezil—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00458	CcSEcCtD
Donepezil—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00456	CcSEcCtD
Donepezil—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00451	CcSEcCtD
Donepezil—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0045	CcSEcCtD
Donepezil—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00449	CcSEcCtD
Donepezil—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00446	CcSEcCtD
Donepezil—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00445	CcSEcCtD
Donepezil—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00445	CcSEcCtD
Donepezil—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00436	CcSEcCtD
Donepezil—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00432	CcSEcCtD
Donepezil—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00413	CcSEcCtD
Donepezil—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00412	CcSEcCtD
Donepezil—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00411	CcSEcCtD
Donepezil—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00411	CcSEcCtD
Donepezil—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00409	CcSEcCtD
Donepezil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00408	CcSEcCtD
Donepezil—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00406	CcSEcCtD
Donepezil—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00403	CcSEcCtD
Donepezil—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00396	CcSEcCtD
Donepezil—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00383	CcSEcCtD
Donepezil—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00369	CcSEcCtD
Donepezil—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00367	CcSEcCtD
Donepezil—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00363	CcSEcCtD
Donepezil—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0036	CcSEcCtD
Donepezil—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00358	CcSEcCtD
Donepezil—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00353	CcSEcCtD
Donepezil—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00351	CcSEcCtD
Donepezil—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0035	CcSEcCtD
Donepezil—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00347	CcSEcCtD
Donepezil—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00344	CcSEcCtD
Donepezil—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00337	CcSEcCtD
Donepezil—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00335	CcSEcCtD
Donepezil—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00332	CcSEcCtD
Donepezil—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00331	CcSEcCtD
Donepezil—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00329	CcSEcCtD
Donepezil—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00323	CcSEcCtD
Donepezil—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00321	CcSEcCtD
Donepezil—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00312	CcSEcCtD
Donepezil—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0031	CcSEcCtD
Donepezil—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00309	CcSEcCtD
Donepezil—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00305	CcSEcCtD
Donepezil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00305	CcSEcCtD
Donepezil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00305	CcSEcCtD
Donepezil—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00304	CcSEcCtD
Donepezil—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00301	CcSEcCtD
Donepezil—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00298	CcSEcCtD
Donepezil—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00294	CcSEcCtD
Donepezil—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00292	CcSEcCtD
Donepezil—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0029	CcSEcCtD
Donepezil—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00286	CcSEcCtD
Donepezil—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00286	CcSEcCtD
Donepezil—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00282	CcSEcCtD
Donepezil—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00278	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00266	CcSEcCtD
Donepezil—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00264	CcSEcCtD
Donepezil—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00262	CcSEcCtD
Donepezil—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0026	CcSEcCtD
Donepezil—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0026	CcSEcCtD
Donepezil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00257	CcSEcCtD
Donepezil—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00254	CcSEcCtD
Donepezil—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00252	CcSEcCtD
Donepezil—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00252	CcSEcCtD
Donepezil—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0025	CcSEcCtD
Donepezil—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0025	CcSEcCtD
Donepezil—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00241	CcSEcCtD
Donepezil—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00239	CcSEcCtD
Donepezil—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00232	CcSEcCtD
Donepezil—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00231	CcSEcCtD
Donepezil—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00231	CcSEcCtD
Donepezil—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00124	0.116	CbGeAlD
Donepezil—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00215	CcSEcCtD
Donepezil—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00209	CcSEcCtD
Donepezil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00207	CcSEcCtD
Donepezil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.002	CcSEcCtD
Donepezil—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00193	CcSEcCtD
Donepezil—SIGMAR1—nephron tubule—focal segmental glomerulosclerosis	0.00106	0.0998	CbGeAlD
Donepezil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00186	CcSEcCtD
Donepezil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00184	CcSEcCtD
Donepezil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00184	CcSEcCtD
Donepezil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00183	CcSEcCtD
Donepezil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000956	0.00173	CcSEcCtD
Donepezil—SIGMAR1—cortex of kidney—focal segmental glomerulosclerosis	0.00091	0.0854	CbGeAlD
Donepezil—HTR2A—kidney—focal segmental glomerulosclerosis	0.000498	0.0467	CbGeAlD
Donepezil—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000461	0.0433	CbGeAlD
Donepezil—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000453	0.0426	CbGeAlD
